General Accident Insurance Company Jamaica Limited (JMSE:GENAC)
8.87
+1.16 (15.05%)
At close: May 22, 2026
JMSE:GENAC Income Statement
Financials in millions JMD. Fiscal year is January - December.
Millions JMD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 13,625 | 13,067 | 11,427 | 8,576 | 6,667 | 3,033 |
Total Interest & Dividend Income | 286.28 | 253.17 | 238.76 | 222.19 | 254.18 | 219.72 |
Gain (Loss) on Sale of Investments | 187.31 | 187.31 | 43.18 | -2.87 | 131.1 | - |
Other Revenue | - | - | - | - | - | 909.08 |
| 14,099 | 13,508 | 11,709 | 8,795 | 7,052 | 4,162 | |
Revenue Growth (YoY) | 15.17% | 15.36% | 33.13% | 24.72% | 69.45% | 9.79% |
Policy Benefits | 12,902 | 12,524 | 11,178 | 7,880 | 6,047 | 1,751 |
Policy Acquisition & Underwriting Costs | - | - | - | - | - | 511.03 |
Selling, General & Administrative | 25.41 | 25.41 | 38.99 | 36.26 | 33.17 | 1,583 |
Other Operating Expenses | 446.69 | 378.42 | 190.7 | 233.92 | 161.23 | 164.66 |
Total Operating Expenses | 13,374 | 12,927 | 11,408 | 8,150 | 6,242 | 4,010 |
Operating Income | 724.38 | 580.26 | 301.1 | 645.25 | 810.1 | 151.6 |
Interest Expense | - | - | - | - | - | -7.4 |
Currency Exchange Gain (Loss) | 32.76 | 32.76 | -22.98 | 70.08 | 2.93 | 102.09 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.33 |
EBT Excluding Unusual Items | 757.15 | 613.02 | 278.13 | 715.33 | 813.04 | 246.62 |
Gain (Loss) on Sale of Assets | - | - | - | 1.17 | 0.32 | 6.27 |
Asset Writedown | - | - | 21.54 | 24 | 77.97 | 6.8 |
Pretax Income | 757.15 | 613.02 | 299.67 | 740.5 | 891.33 | 259.7 |
Income Tax Expense | 205.9 | 161.5 | 51.34 | 192.23 | 110.94 | 110.46 |
Earnings From Continuing Ops. | 551.25 | 451.52 | 248.32 | 548.27 | 780.39 | 149.24 |
Minority Interest in Earnings | -21.94 | -9.57 | -6.99 | -8.09 | -49.65 | 105.51 |
Net Income | 529.3 | 441.95 | 241.33 | 540.18 | 730.74 | 254.75 |
Net Income to Common | 529.3 | 441.95 | 241.33 | 540.18 | 730.74 | 254.75 |
Net Income Growth | 60.52% | 83.13% | -55.32% | -26.08% | 186.85% | 5.05% |
Shares Outstanding (Basic) | 1,037 | 1,031 | 1,031 | 1,031 | 1,031 | 1,031 |
Shares Outstanding (Diluted) | 1,037 | 1,031 | 1,031 | 1,031 | 1,031 | 1,031 |
EPS (Basic) | 0.51 | 0.43 | 0.23 | 0.52 | 0.71 | 0.25 |
EPS (Diluted) | 0.51 | 0.43 | 0.23 | 0.52 | 0.71 | 0.25 |
EPS Growth | 56.45% | 83.13% | -55.32% | -26.08% | 186.85% | 5.05% |
Free Cash Flow | -41.82 | 2,188 | 994.2 | 150.26 | -426.49 | -382.55 |
Free Cash Flow Per Share | -0.04 | 2.12 | 0.96 | 0.15 | -0.41 | -0.37 |
Dividend Per Share | 0.078 | 0.078 | 0.218 | 0.196 | 0.243 | 0.191 |
Dividend Growth | -64.44% | -64.44% | 11.09% | -19.17% | 27.41% | -11.68% |
Operating Margin | 5.14% | 4.30% | 2.57% | 7.34% | 11.49% | 3.64% |
Profit Margin | 3.75% | 3.27% | 2.06% | 6.14% | 10.36% | 6.12% |
Free Cash Flow Margin | -0.30% | 16.20% | 8.49% | 1.71% | -6.05% | -9.19% |
EBITDA | 854.54 | 704.52 | 394.36 | 734.24 | 882.43 | 220.79 |
EBITDA Margin | 6.06% | 5.22% | 3.37% | 8.35% | 12.51% | 5.31% |
D&A For EBITDA | 130.16 | 124.26 | 93.25 | 88.98 | 72.33 | 69.19 |
EBIT | 724.38 | 580.26 | 301.1 | 645.25 | 810.1 | 151.6 |
EBIT Margin | 5.14% | 4.30% | 2.57% | 7.34% | 11.49% | 3.64% |
Effective Tax Rate | 27.19% | 26.35% | 17.13% | 25.96% | 12.45% | 42.53% |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.